πŸ‡ΊπŸ‡Έ FDA
Patent

US 7767645

SH2 domain binding inhibitors

granted A61KA61K38/00

Quick answer

US patent 7767645 (SH2 domain binding inhibitors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00